- Home
- JDZG vs IGC Comparison
JDZG vs IGC Comparison
Compare JDZG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- IGC
- Stock Information
- Founded
- JDZG 2020
- IGC 2005
- Country
- JDZG China
- IGC United States
- Employees
- JDZG N/A
- IGC N/A
- Industry
- JDZG Other Consumer Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- IGC Health Care
- Exchange
- JDZG Nasdaq
- IGC Nasdaq
- Market Cap
- JDZG 7.5M
- IGC 20.2M
- IPO Year
- JDZG 2024
- IGC N/A
- Fundamental
- Price
- JDZG $2.50
- IGC $0.38
- Analyst Decision
- JDZG
- IGC Strong Buy
- Analyst Count
- JDZG 0
- IGC 2
- Target Price
- JDZG N/A
- IGC $3.88
- AVG Volume (30 Days)
- JDZG 78.3K
- IGC 6.7M
- Earning Date
- JDZG 07-22-2025
- IGC 08-07-2025
- Dividend Yield
- JDZG N/A
- IGC N/A
- EPS Growth
- JDZG N/A
- IGC N/A
- EPS
- JDZG 0.25
- IGC N/A
- Revenue
- JDZG $2,567,741.00
- IGC $1,271,000.00
- Revenue This Year
- JDZG N/A
- IGC $15.26
- Revenue Next Year
- JDZG N/A
- IGC $3.41
- P/E Ratio
- JDZG $10.07
- IGC N/A
- Revenue Growth
- JDZG 20.36
- IGC N/A
- 52 Week Low
- JDZG $1.61
- IGC $0.25
- 52 Week High
- JDZG $21.28
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- IGC 65.10
- Support Level
- JDZG N/A
- IGC $0.30
- Resistance Level
- JDZG N/A
- IGC $0.46
- Average True Range (ATR)
- JDZG 0.00
- IGC 0.02
- MACD
- JDZG 0.00
- IGC 0.01
- Stochastic Oscillator
- JDZG 0.00
- IGC 48.81
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.